Robert Gish
University of Nevada Las Vegas School of Medicine
Appearances
DateMay 20, 2024INTRODUCTION: Elevated levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are associated with risk of poor clinical outcomes, including hepatic decompensation, liver transplant, or death, in patients (pts) with primary biliary cholangitis (PBC)…Speakers
Presenter
DateMay 21, 2024SOCIETY: AASLDModerators
University of Nevada Las Vegas School of MedicineIcahn School of Medicine at Mount Sinai- DateMay 18, 2024INTRODUCTION: Transient elastography (TE) is a noninvasive alternative to biopsy for assessment of liver stiffness and indirectly fibrosis, which can be predictive of adverse outcomes in patients with primary biliary cholangitis (PBC)…
Presenter
University of Nevada Las Vegas School of Medicine 
DateMay 18, 2024METABOLIC OUTCOMES AND KEY EFFICACY DATA FROM A PHASE 2 TRIAL EVALUATING COMBINATION OBETICHOLIC ACID AND BEZAFIBRATE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITISModerators
Indiana UniversityUniversity of Southern CaliforniaSpeakers
University of Nevada Las Vegas School of Medicine
